Terminology Service for NFDI4Health

R-GVD Regimen

Go to external page http://purl.obolibrary.org/obo/NCIT_C140733


A regimen consisting of rituximab, gemcitabine, vinorelbine and pegylated liposomal doxorubicin that can be used in the treatment of Hodgkin lymphoma (HL) and diffuse large B-cell lymphoma (DLBCL). [ ]

Term info

Label

R-GVD Regimen

Synonyms
  • Gemcitabine-Vinorelbine-Pegylated Liposomal Doxorubicin-Rituximab
  • Gemcitabine/Vinorelbine/Doxil/Rituximab
  • Gemcitabine/Vinorelbine/Pegylated Liposomal Doxorubicin/Rituximab
  • R-GVD
  • R-GVD Regimen
  • Rituximab/Gemcitabine/Vinorelbine/Pegylated Liposomal Doxorubicin
Subsets

NCIT_C160952, NCIT_C160950

NCI META CUI

CL538819

Preferred Name

R-GVD Regimen

Semantic Type

Therapeutic or Preventive Procedure

code

C140733